Supporting Treatment Adherence Needs in Diabetes
| Status: | Completed |
|---|---|
| Conditions: | Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 13 - 17 |
| Updated: | 4/2/2016 |
| Start Date: | September 2009 |
| End Date: | September 2012 |
| Contact: | Korey K Hood, PhD |
| Email: | korey.hood@cchmc.org |
| Phone: | (513) 803-0405 |
Supporting Treatment Adherence Needs in Diabetes: The STAND Study
There is an unmet treatment need for depressed adolescents with type 1 diabetes. To address
this unmet need, we have designed a new, family-based, cognitive-behavioral intervention to
reduce depressive symptoms, improve family functioning, and improve medication compliance.
The intervention is delivered in two phases (1 - reduction of depressive symptoms and family
conflict, 2 - adherence promotion) as efforts to improve adherence will have a greater
likelihood of success if individual and family functioning variables are addressed first. To
test the effectiveness of this intervention in reducing depressive symptoms and improving
adherence, we will conduct a randomized controlled trial comparing this new intervention to
usual care in a sample of fifty-two adolescents with type 1 diabetes and their primary
caregivers. Given the absence of this type of intervention and the significance of the
problem, this study is timely and important, as it has the potential to positively impact
diabetes-specific health outcomes.
this unmet need, we have designed a new, family-based, cognitive-behavioral intervention to
reduce depressive symptoms, improve family functioning, and improve medication compliance.
The intervention is delivered in two phases (1 - reduction of depressive symptoms and family
conflict, 2 - adherence promotion) as efforts to improve adherence will have a greater
likelihood of success if individual and family functioning variables are addressed first. To
test the effectiveness of this intervention in reducing depressive symptoms and improving
adherence, we will conduct a randomized controlled trial comparing this new intervention to
usual care in a sample of fifty-two adolescents with type 1 diabetes and their primary
caregivers. Given the absence of this type of intervention and the significance of the
problem, this study is timely and important, as it has the potential to positively impact
diabetes-specific health outcomes.
Inclusion Criteria:
- Age 13-17
- Diagnosis of type 1 diabetes according to criteria from the ADA for at least 1 year
- Daily insulin dosing of at least 0.5 units per kilogram per day
- Clinical elevation on the CDI (i.e., score at or above 13)
- Assent to participation in study
Exclusion Criteria:
- Other chronic, physical disease or condition except for celiac or thyroid disease
- Diagnosis of major mental disorder (e.g., bipolar disorder, thought disorder,
anorexia nervosa)
- Diagnosis of developmental disorder (e.g., mental retardation, autism, Asperger's)
- Current enrollment in psychotherapy specifically targeting depression
We found this trial at
1
site
3333 Burnet Avenue # Mlc3008
Cincinnati, Ohio 45229
Cincinnati, Ohio 45229
1-513-636-4200
Cincinnati Children's Hospital Medical Center Patients and families from across the region and around the...
Click here to add this to my saved trials
